Titel

Merkliste
1 Ergebnisse

Radiochemotherapy with or without cetuximab for unresectabl..:

Rades, Dirk ; Bartscht, Tobias ; Hunold, Peter...
https://repository.publisso.de/resource/frl:6441797. , 2020

Link: https://repository.publisso.de/resource/frl:6441797

RT Journal
T1 <Title>Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftzbmed:oai:frl.publisso.de:frl:6441797&Exemplar=1&LAN=DE
				
A1 Rades, Dirk
A1 Bartscht, Tobias
A1 Hunold, Peter
A1 Schmidberger, Heinz
A1 König, Laila
A1 Debus, Jürgen
A1 Belka, Claus
A1 Homann, Nils
A1 Spillner, Patrick
A1 Petersen, Cordula
A1 Kuhnt, Thomas
A1 Fietkau, Rainer
A1 Ridwelski, Karsten
A1 Karcher-Kilian, Kerstin
A1 Kranich, Anne
A1 Männikkö, Sofia
A1 Schild, Steven E
A1 Maderer, Annett
A1 Moehler, Markus
YR 2020
K1 Antineoplastic Agents
K1 Immunological/adverse effects [MeSH]
K1 Female [MeSH]
K1 Aged
K1 80 and over [MeSH]
K1 Esophageal Neoplasms/therapy [MeSH]
K1 Aged [MeSH]
K1 Adult [MeSH]
K1 Humans [MeSH]
K1 EGFR antibody
K1 Progression-Free Survival [MeSH]
K1 Middle Aged [MeSH]
K1 Cetuximab/therapeutic use [MeSH]
K1 Efficacy
K1 Original Article
K1 Feasibility
K1 Male [MeSH]
K1 Immunological/therapeutic use [MeSH]
K1 Disease-Free Survival [MeSH]
K1 Esophageal cancer
K1 Cetuximab/adverse effects [MeSH]
K1 Chemoradiotherapy/adverse effects [MeSH]
K1 Definitive treatment
JF https://repository.publisso.de/resource/frl:6441797
LK http://dx.doi.org/https://repository.publisso.de/resource/frl:6441797
DO https://repository.publisso.de/resource/frl:6441797
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)